Valuation: DiaSorin S.p.A.

Market Cap 4.09B 4.56B 3.74B 3.41B 6.43B 429B 6.63B 45.06B 17.97B 229B 17.12B 16.75B 722B P/E 2026 *
25x
P/E 2027 * 21.4x
Enterprise Value 4.78B 5.33B 4.37B 3.99B 7.52B 501B 7.76B 52.71B 21.02B 268B 20.02B 19.6B 845B EV / Sales 2026 *
3.87x
EV / Sales 2027 * 3.54x
Free-Float
37.17%
Yield 2026 *
1.57%
Yield 2027 * 1.64%
1 day+2.48%
1 week+2.58%
Current month+2.58%
1 month+7.41%
3 months+10.99%
6 months+31.47%
Current year+20.43%
1 week 78.94
Extreme 78.94
82.68
1 month 74.84
Extreme 74.84
82.68
Current year 52.34
Extreme 52.34
82.68
1 year 52.34
Extreme 52.34
82.68
3 years 52.34
Extreme 52.34
112.35
5 years 52.34
Extreme 52.34
194.3
10 years 49.98
Extreme 49.98
211.8
Manager TitleAgeSince
Chief Executive Officer 60 26/03/2007
Director of Finance/CFO - 01/01/2025
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 60 28/04/2016
Director/Board Member 63 26/03/2007
Chairman 57 29/04/2022
Date Insider Type Main position Quantity % Market Cap. Importance
24/03/26 Buy

Chief Executive Officer

9,211 0.0165%
28/01/26 Buy

Chief Executive Officer

7,500 0.0134%
08/01/26 Buy

Director

700 0.0013%
Change 5-day change 1-year change 3-year change Capi.($)
+2.48%+2.58%+37.00%-4.79% 4.48B
-3.23%+3.51%-12.02%+15.72% 197B
-2.90%+5.45%+13.04%+38.65% 128B
-2.75%+11.65%-7.90%+17.71% 128B
+0.96%+5.15%-38.02%+12.24% 99B
-1.80%+0.82%-7.41%+69.42% 64.82B
-0.78%+7.07%+19.44%-18.22% 58.17B
+0.79%+22.65%-5.28%+59.81% 52.84B
-6.98%-14.56%-12.60%+42.69% 50.69B
-2.36%+3.72%+3.27%-8.07% 37.23B
Average -1.66%+5.66%-1.05%+22.52% 81.99B
Weighted average by Cap. -2.21%+6.09%-6.64%+24.35%

Financials

2026 *2027 *
Net sales 1.24B 1.38B 1.13B 1.03B 1.94B 129B 2B 13.61B 5.43B 69.07B 5.17B 5.06B 218B 1.31B 1.47B 1.2B 1.1B 2.07B 138B 2.13B 14.48B 5.77B 73.49B 5.5B 5.38B 232B
Net income 181M 202M 166M 151M 285M 18.98B 294M 2B 796M 10.13B 758M 742M 31.98B 205M 228M 187M 171M 322M 21.44B 332M 2.25B 899M 11.44B 856M 838M 36.11B
Net Debt 694M 774M 635M 579M 1.09B 72.77B 1.13B 7.65B 3.05B 38.83B 2.91B 2.84B 123B 556M 619M 508M 463M 873M 58.22B 901M 6.12B 2.44B 31.07B 2.32B 2.27B 98.07B
Projected Income Statement - Annual - DiaSorin S.p.A.
Logo DiaSorin S.p.A.
DiaSorin SpA is an Italy-based company engaged in healthcare industry. The Company specializes in provision of developing, producing and commercializing reagent kits for the in vitro diagnostics. The Company develops and manufactures reagents for in vitro diagnostics and produces products for the fields of infectious disease, hepatitis, endocrinology, bone & mineral metabolism, cancer, brain injury, cardiac, therapeutic drug monitoring and autoimmunity. The Company’s business activities are divided into two markets. The Immunodiagnostics market develops, produces and markets immunoreagent kits, which are based on three techniques: Chemiluminescence (CLIA), Colorimetry (ELISA) and Radioimmunometry (RIA). The Molecular Diagnostics market supplies end laboratories with an automated result to perform the three steps for the final diagnostic result, including nucleic acids extraction, amplification and diagnosis. It operates through ELISA immunodiagnostic business portfolio.
Employees
3,260
Date Price Change Volume
06/11/26 €82.64 +2.48% 209,900
05/11/26 €80.64 -1.87% 104,873
04/11/26 €82.18 +2.21% 171,206
03/11/26 €80.40 +0.07% 66,669
02/11/26 €80.34 -0.27% 87,481
Trader
Investor
Global
Quality
ESG MSCI
BBB
MarketScreener Ratings - DiaSorin S.p.A.
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
14
Last Close Price
82.64EUR
Average target price
76.38EUR
Spread / Average Target
-7.58%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - DiaSorin S.p.A.